Functional Glycomics in HIV Vaccine Design: Funding Opportunity and Workshop Report

The NIH is offering R01 grants to help investigate structural and conformational features of HIV glycosylation that may lead to novel HIV vaccine design approaches; and to elucidate the impact of differential glycosylation on the quality of the immune response to HIV.  The deadline to apply is 02 December,

In April, the NIH, with support from the Enterprise, hosted a workshop, Functional Glycomics in HIV-1 Vaccine Design, to help determine how new information on the role of glycans could be applied to HIV immunogen design strategies.  The full meeting report was published in AIDS Research and Human Retroviruses

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account